A Phase II trial of tipifarnib (R15777, Zarnestra) in combination with tamoxifen in subjects with metastatic breast cancer
Phase of Trial: Phase II
Latest Information Update: 18 Jun 2013
At a glance
- Drugs Tipifarnib (Primary) ; Tamoxifen
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 13 Dec 2008 Trial phase changed from I/II to II as reported by ClinicalTrials.gov.
- 19 Aug 2005 New trial record.